The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the National Digestive Diseases Advisory Board

Hepatology

Volumn 22, Issue 5, 1995, Pages 1591-1597

  Shiffman, Mitchell L ^a   Jeffers, Lennox ^a   Hoofnagle, Jay H ^a   Sue Tralka, Tommie ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCITES; BUDD CHIARI SYNDROME; HEPATIC ENCEPHALOPATHY; HUMAN; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT PLANNING;

HUMAN; HYPERTENSION, PORTAL; PORTASYSTEMIC SHUNT, SURGICAL;

EID: 0028886215     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90169-8     Document Type: Article

References (78)

1. Production of nonsurgical portosystemic venous shunts in dogs by transjugular approach
2. Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience
3. Transjugular intrahepatic portosystemic shunt: a nonoperative approach to life-threatening variceal bleeding
4. Expandable intrahepatic portacaval shunt stents in dogs with chronic portal hypertension
5. Experimental intrahepatic portacaval anastomosis: use of expandable gianturco stents
6. Coaxial catheterneedle system for transjugular portal vein entrance
7. Transjugular intrahepatic portosystemic stent shunt (TIPSS): early clinical experience
8. Transjugular intrahepatic portal-systemic shunts: the state of the art
9. Evolution and clinical introduction of TIPSS, the transjugular intrahepatic portosystemic stent-shunt
10. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients
11. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding
12. Transjugular intrahepatic-portasystemic stent shunting for control of acute and recurrent upper gastrointestinal haemorrhage related to portal hypertension
13. Percutaneous transjugular portosystemic shunt
14. Transjugular intrahepatic portosystemic shunt vs. sclerotherapy for prevention of recurrent variceal hemorrage: a randomized controlled trial
15. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review
16. Complications of transjugular intrahepatic portal systemic shunting (TIPS)
17. Portosystemic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): results of a prospective controlled study
18. Factors influencing the incidence of hepatic encephalopathy in patients with transjugular intrahepatic portosystemic stentshunt (TIPS)
19. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors
20. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation
21. The transjugular intrahepatic portosystemic shunt (TIPS): an alternative for the management of life-threatening variceal hemorrhage
22. Transjugular intrahepatic portacaval stent shunt as a rescue treatment for life-threatening variceal bleeding in a cirrhotic patient with severe liver failure
23. Transjugular intrahepatic portosystemic shunt (TIPS) for uncontrolled variceal hemorrhage in advanced cirrhotics at high-risk for surgery: a prospective study
24. Bleeding gastroesophageal varices
25. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage
26. Esophageal transection versus injection sclerotherapy in the management of bleeding esophageal varicies in patients at high risk
27. Randomized trial of portacaval shunt stapling transection and endoscopic sclerotherapy in uncontrolled variceal bleeding
28. Results with percutaneous transjugular intrahepatic portosystemic stent-shunts for control of variceal hemorrhage in patients awaiting liver transplantation
29. Intrahepatic portosystemic vascular stents: a bridge to hepatic transplantation
30. Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding
31. Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal hemorrhage
32. Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy
33. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage
34. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis
35. Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal bleeding
36. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites
37. Comparison of paracentesis and diuretics in the treatment of cirrhosis with tense ascites
38. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites
39. Transjugular intrahepatic porto-systemic shunt for ascites: a preliminary report
40. Transjugular intrahepatic portosystemic shunt for refractory ascites: assessment of clinical and humoral response and renal function
41. Transjugular intrahepatic portosystemic shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites
42. Successful treatment of massive hepatic hydrothorax (HH) with transjugular portosystemic shunt (TIPS)
43. Role of transjugular intrahepatic portosystemic shunt (TIPS) in the primary management of refractory cirrhotic hydrothorax
44. Budd-Chiari syndrome: etiology, diagnosis and management
45. Approach to the spectrum of Budd-Chiari syndrome: which patients require portal decompression
46. The Budd-Chiari syndrome
47. Liver transplantation for the Budd-Chiari syndrome
48. Dilatation of the inferior vena cava using an expandable metal stent in BuddChiari syndrome
49. Expandable venous stents for treatment of the Budd-Chiari syndrome
50. Treatment of Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt
51. Feasibility of transjugular intrahepatic portosystemic stent shunt (TIPS) in the treatment of fulminant Budd-Chiari Syndrome (BCS)
52. Percutaneous placement of a hepatic vein stent in the treatment of BuddChiari syndrome
53. Prevention of first bleeding in cirrhosis: a meta-analysis of randomized trials of non-surgical treatment
54. Prophylactic sclerotherapy before the first episode of esophageal hemorrhage in patients with cirrhosis
55. Prophylactic sclerotherapy of high risk esophageal varicies: results of a multicentric prospective controlled trial
56. NIDDK Liver Transplantation Database (LTD)
57. Recurrent variceal hemorrhage despite a patent transjugular intrahepatic portosystemic shunt (TIPS)
58. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion
59. Transjugular intrahepatic portosystem stent-shunt (TIPS): technical and early clinical complications
60. Delayed wallstent migration after a transjugular intrahepatic portosystemic shunt procedure: relocation with a loop snare
61. Percutaneous removal of an embolized wallstent during a transjugular intrahepatic portosystemic shunt procedure
62. Risk of adverse hemodynamic effects after intrahepatic shunts (TIPS): preliminary results
63. TIPS-associated hemolysis and encephalopathy
64. Hemolysis following transjugular intrahepatic portosystemic shunt (TIPS)
65. Hepatic arterial injury after transjugular intrahepatic portosystemic shunt placement: report of two cases
66. Delayed fatal cardiac perforation by an indwelling long introducer sheath following transjugular intrahepatic portocaval stents (TIPS)
67. Experimental intrahepatic portocaval shunts created in portal hypertension by balloon angioplasty catheters
68. Distal splenorenal shunt vs portal-systemic shunt: current status of a controlled trial
69. Porto-systemic encephalopathy and portacaval anastamosis: a prospective controlled investigation
70. Encephalopathy, ascites, and hepatic synthetic function after TIPS for variceal hemorrhage
71. The transjugular intrahepatic portosystemic stent-shunt: factors influencing shunt patency
72. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement
73. Shunt patency recurrent bleeding and survival after transjugular intrahepatic portosystemic shunt (TIPS) for variceal hemorrhage
74. Recurrence of portal hypertension (PH) following transjugular intrahepatic portosystemic shunts (TIPS): mechanisms and therapy
75. Histopathologic study of transjugular intrahepatic portosystemic shunts
76. Transjugular intrahepatic portosystemic shunt: evaluation with doppler sonography
77. Transjugular intrahepatic porto-systemic shunt (TIPS) and pathophysiology of portal hypertension: endoscopic, radiologic and biochemical correlations
78. Role of parallel transjugular intrahepatic portosystemic shunts in patients with persistent portal hypertension